Platelet-Rich Plasma for Treating Female Androgenic Alopecia: A Systematic Review

April 2021 in “ Journal of Investigative Dermatology ”

G.E. Beraja, R.L. Quinonez, Jose L. Jimenez

platelet-rich plasma female androgenic alopecia PRP androgenic alopecia hair growth hair loss AGA

TLDR PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

The document titled "277 Platelet-rich plasma for treating female androgenic alopecia: A systematic review" reviews the effectiveness of platelet-rich plasma (PRP) in treating female androgenic alopecia (AGA). The study found that PRP treatment can be effective in promoting hair growth and reducing hair loss in women with AGA. However, more research is needed to determine the optimal PRP treatment protocol and to fully understand the long-term effects of PRP treatment for AGA.

View this study on jidonline.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 81 results

community Has anyone had experience with PRP causing or exasperating alopecia areata?

in General 96 upvotes 1 month ago

A 33-year-old female with androgenic alopecia experienced alopecia areata patches after PRP treatment. She is seeking others' experiences with PRP worsening alopecia areata.

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 828 upvotes 5 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Evidenced Based Meta-Analyses and Systemic Reviews of Androgenic Alopecia and Treatments

in Research/Science 14 upvotes 4 years ago

Evidence-based treatments for androgenic alopecia, such as minoxidil, finasteride, low-level laser light therapy, dutasteride, platelet-rich plasma, and topical ketoconazole. It discusses the efficacy, safety, and mechanism of action of these treatments, as well as future developments in understanding this polygenic condition.

community 21F AGA - 4 month hair growth progress (Minoxidil 5%, finasteride 1mg, theradome LLLT, viviscal vitamins, PRP twice)

in Progress Pictures 256 upvotes 3 years ago

A 21-year-old female shared her 4-month hair growth progress using Minoxidil 5%, finasteride 1mg, Theradome LLLT, Viviscal vitamins, and PRP treatments twice. Commenters praised her progress and discussed other treatments like microneedling, but she noted her dermatologist advised against it due to potential scalp damage.

community When are we getting a cure to hair loss?

in Chat 1 year ago

Potential treatments for hair loss, including Minoxidil, finasteride, RU58841 and various upcoming pharmaceuticals, gene editing and cloning. It is suggested that a cure, if found, would be highly profitable due to the large number of people affected by hair loss globally.

community Most Recent Interesting Hairloss Studies: 10% Minox vs 5% Minox / Radio Rrequency Treatment for AA / Topical Ketoconazole / PRP+Minox vs Minox vs PRP / Alopecia as a systemic disease

in Treatment 87 upvotes 5 years ago

Treatments for hair loss, such as topical minoxidil, platelet-rich plasma therapy with or without minoxidil, ketoconazole, non-abative radio frequency, natural products, finasteride and cortexolone 17 alpha propionate. The post evaluates the efficacy and safety of these treatments in various studies.

Related Research

9 / 9 results

research Evaluation of Platelet Rich Plasma for Treatment of Female Pattern Hair Loss: A Placebo-Controlled Case Study

December 2022 in “Journal of Dermatology Research”

Platelet Rich Plasma (PRP) treatment significantly improved Female Pattern Hair Loss in a study, but more trials are needed for confirmation.

The Effect of Placebo in Split-Scalp and Whole-Head Platelet-Rich Plasma Trials for Androgenetic Alopecia Differs: Findings from a Systematic Review with Quantitative Evidence Syntheses

research The Effect of Placebo in Split-Scalp and Whole-Head Platelet-Rich Plasma Trials for Androgenetic Alopecia Differs: Findings from a Systematic Review with Quantitative Evidence Syntheses

January 2022 in “Journal of Cosmetic Dermatology”

Placebo effects vary in hair loss trials, with split-scalp trials showing higher hair density after 6 months compared to whole-head trials.

research Effect of Platelet-Rich Plasma (PRP) on Hairfall (Khalitya) Along with Ayurvedic Medicines: A Case Study

August 2021 in “Journal of emerging technologies and innovative research”

PRP combined with Ayurvedic medicine may effectively treat hair loss.

research Platelet-Rich Plasma for Hair Loss

12 citations, January 2021 in “Springer eBooks”

research A Pilot Study of Intrascalp Platelet-Rich Plasma Injections for Hair Loss in Nigerian Patients

November 2020 in “Journal of The American Academy of Dermatology”

The conclusion is that many small genetic variations influence claw disorders in cows, and using genomic selection could help reduce these disorders.

research Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia

87 citations, September 2016 in “Dermatologic Surgery”

PRP shows potential for treating female hair loss, but more research needed.

research Platelet-Rich Plasma as a Potential Treatment for Noncicatricial Alopecias

58 citations, January 2015 in “International Journal of Trichology”

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

research Experience Using Platelet-Rich Plasma in the Treatment of Androgenic Alopecia

April 2014 in “The FASEB Journal”

Platelet-rich plasma therapy can reduce hair loss and enhance hair growth in androgenetic alopecia patients, with no side effects observed.

research Disorders of Hair

July 2013 in “DeckerMed Medicine”

The document's conclusion cannot be provided because the document is not readable or understandable.